In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Nektar Therapeutics (NASDAQ: NKTR) closed the day trading at $0.67 down -1.30% from the previous closing price of $0.67. In other words, the price has decreased by -$1.30 from its previous closing price. On the day, 2.04 million shares were traded.
Ratios:
For a better understanding of NKTR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.24 and its Current Ratio is at 3.24. In the meantime, Its Debt-to-Equity ratio is 13.59 whereas as Long-Term Debt/Eq ratio is at 12.00.
On March 14, 2025, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $6.
On January 08, 2025, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $4.B. Riley Securities initiated its Buy rating on January 08, 2025, with a $4 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 19 ’25 when Zalevsky Jonathan sold 10,712 shares for $0.67 per share. The transaction valued at 7,177 led to the insider holds 305,892 shares of the business.
Wilson Mark Andrew sold 9,996 shares of NKTR for $6,697 on May 19 ’25. The Chief Legal Officer now owns 314,296 shares after completing the transaction at $0.67 per share. On May 19 ’25, another insider, ROBIN HOWARD W, who serves as the President & CEO of the company, sold 23,208 shares for $0.67 each. As a result, the insider received 15,549 and left with 1,063,693 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.42 while its Price-to-Book (P/B) ratio in mrq is 9.02.
Stock Price History:
Over the past 52 weeks, NKTR has reached a high of $1.52, while it has fallen to a 52-week low of $0.43. The 50-Day Moving Average of the stock is -0.54%, while the 200-Day Moving Average is calculated to be -31.64%.
Shares Statistics:
A total of 186.10M shares are outstanding, with a floating share count of 179.42M. Insiders hold about 3.59% of the company’s shares, while institutions hold 64.58% stake in the company.
